0
0
Screening for Comorbidities Is Important to Guide Treatment Selection in PsA - Rheumatology Advisor
11/21/22 at 3:09pm
33 words
0
Comments
A GRAPPA working group highlighted the importance of screening for comorbidities to guide treatment selection among patients with psoriatic arthritis.
You are the first to view
https://www.rheumatologyadvisor.com/home/topics/psoriatic-arthritis/screening-for-comorbidities-is-important-to-guide-treatment-selection-in-psa/
Create an account or login to join the discussion